In the event of interruption or cessation of activity of a pharmaceutical establishment mentioned in article L. 5124-1 or article L. 5124-9-1 manufacturing advanced therapy medicinal products prepared on an ad hoc basis, the data relating to the traceability of these medicinal products are transferred to the Agence nationale de sécurité du médicament et des produits de santé
Article R5121-201-8
Updated 2 Nov 2023

